Since being named dean of the UB School of Medicine and Biomedical Sciences, Michael E. Cain, MD, has appointed six new chairs and high-level physician-scientists.
The National Heart, Lung and Blood Institute of the National Institutes of Health (NIH) has stopped the AIM-HIGH clinical research trial 18 months earlier than planned due to lack of efficacy in reducing cardiovascular events.
